The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Safety and use of bendamustine from the Bendamustine Expanded Access Trial in Canada (Bend-ACT).
C. Tom Kouroukis
Consultant or Advisory Role - Lundbeck
Honoraria - Lundbeck
Michael Crump
Honoraria - Lundbeck
David MacDonald
Consultant or Advisory Role - Lundbeck Canada
Honoraria - Lundbeck Canada
Jean-Francois Larouche
Consultant or Advisory Role - Lundbeck
Honoraria - Lundbeck
Research Funding - Lundbeck
Douglas Allan Stewart
Honoraria - Lundbeck
Other Remuneration - Lundbeck
James B Johnston
Consultant or Advisory Role - Lundbeck
Stéphanie Sauvageau
No relevant relationships to disclose
Stéphanie G. Dubois
No relevant relationships to disclose
Laurie Helen Sehn
Consultant or Advisory Role - Lundbeck
Honoraria - Lundbeck
Research Funding - Lundbeck